The autologous cancer vaccine is a personalized treatment created from the patient’s deactivated tumor cells. Treatments like these work to activate the immune system against specific tumor-associated antigens found on the outside surface of the tumor cells that are different than normal ‘self’ cells. Treatments like these allow for a variety of tumor associated antigens to be presented to the immune system. By utilizing a portion of the animal’s own tumor tissue, we create a personalized treatment specific to the individual animal’s cancerous cells.